Extracellular Vesicles in Colorectal Cancer: Mediators of tumor aggressiveness

We selected a limited number of miRNAs for validation in an independent cohort, and verified higher plasma exosomal miR-141-3p and miR-375 in patients presenting with synchronous

Introduction of miR-210 in NSCLC patients expressing low tumor levels may be a potential future treatment approach, especially since miR-210 is associated with a positive

cancer ...34 Table 4.5: Summary of literature search results on circulating miR-141 and prostate cancer ...35 Table 4.6: Summary of literature search results on circulating

In the present study, we report the expression of mir-141 and miR-145 in TE cells and TS areas in human pros- tatectomy specimens and their impact on biochemical failure free

In addition, we used RT-qPCR to compare the expression of mir-193b to well established neuroblastoma oncogenic and tumor suppressor miRNAs in two neuroblastoma

ISH expression of miR-143 and miR-145 in NSCLC cells and metastatic lymph nodes miR-143 was primarily observed in the cytoplasm of tumor epithelial and stromal cells, while

In this unselected population of surgically resected NSCLC patients, high miR-155 expression was an independent negative prognostic factor in ACs, while high miR-155 expression was

Results: In univariate analyses, high tumor cell expression of miR-182 was a positive prognostic factor for patients with squamous cell carcinoma (SCC, P = 0.042) and stage II